Sign in
4

Changes in Ownership

TransMedics Group, Inc. Filed Acc 0000950170-24-044020

President & CEO sold 12,000 shares at $95.09 ($1,141,080)

  • President & CEO acquired 12,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Hassanein Waleed H · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-04-10 Exercise or conversion : show line 1 in the form 10b5-1 +12,000 $13.28 $159,360 86,087 D
2024-04-10 Sale : show line 2 in the form 10b5-1 −12,000 $95.09 $1,141,080 74,087 D
Open-market sales · 12,000 sh · avg $95.09 · $1,141,080

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-04-10 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −12,000 238,000 D
Loading xslF345X05/ownership.xml…